This data indicated that the anti-PD-1 mAb efficacy in controlling MC38 tumor growth largely depended on gut microbiota, which is consistent with the observations in MCA-205 sarcoma and RET melanoma mice model 7. Here, PDCD1 is linked to neoplasm.